Search company, investor...

Intact Medical

intactmedical.com

Founded Year

1998

Stage

Acquired | Acquired

Total Raised

$53.18M

About Intact Medical

Intact Medical markets, designs, and develops minimally invasive systems for the volumetric excision of tissue for diagnostic and therapeutic applications in select cancer markets. Initial products will be targeted at breast biopsy.

Headquarters Location

550 Cochituate Road #25

Framingham, Massachusetts, 01701,

United States

508-655-7820

Missing: Intact Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Intact Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Intact Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Intact Medical is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

11,693 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health IT

7,901 items

Intact Medical Patents

Intact Medical has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/12/2016

7/30/2019

Surgical removal procedures, Digestive system surgery, Medical equipment, Aerodynamics, Surgical oncology

Grant

Application Date

8/12/2016

Grant Date

7/30/2019

Title

Related Topics

Surgical removal procedures, Digestive system surgery, Medical equipment, Aerodynamics, Surgical oncology

Status

Grant

Latest Intact Medical News

Biopsy Devices Market Analysis 2026 – Future Growth By Major Players – Boston Scientific Carefusion, Cook Medical, C R Bard, Devicor Medical Products, Hologic, Intact Medical Corporation, Precision Biopsy, LLC, Scion Medical Technologies LLC, Integra LifeSciences Corporation, Creganna

Sep 11, 2018

Coherent Market Insights has announced the addition of the “Global Biopsy Devices Market Size Status and Forecast 2026”, The report classifies the global Biopsy Devices Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining Market growth. Biopsy Devices Market research report covers the present scenario and the growth prospects of the global Biopsy Devices industry for 2018-2026. The report enlists several important factors, starting from the basics to advanced Market intelligence which play a crucial part in strategizing. Biopsy Devices Market report provides key statistics on the Market status of the Biopsy Devices manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Biopsy Devices industry. The Biopsy Devices Market report also presents the vendor landscape and a corresponding detailed analysis of the major vendors operating in the Market. Biopsy Devices Market report 2018-2026 focuses on the major growth factors, revenue opportunities and restraints for the key players. These research report also provides granular analysis of the Market share, segmentation, revenue forecasts and geographic regions of the Market. The Biopsy Devices Market research report is a professional and in-depth study on the current state of Biopsy Devices Industry. Get Sample Copy of Research Report on Biopsy Devices Market, Click – https://www.coherentmarketinsights.com/insight/request-sample/220 Biopsy Devices Market report analyses the Market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and Market demand and supply scenarios. In the end, the report makes some important proposals for a new project of Biopsy Devices Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2018-2026 global Biopsy Devices industry covering all important parameters. Biopsy Devices driver Biopsy Devices trend The Table of Content is presented in Multiple Chapter to display the Global Biopsy Devices Market some of them as Follow Chapter 1, Definition, Specifications and Classification of Biopsy Devices, Applications of Biopsy Devices , Market Segment by Regions; Chapter 2, Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure; Chapter 3, Technical Data and Manufacturing Plants Analysis of Biopsy Devices , Capacity and Commercial Production Date, Manufacturing Plants Distribution, R&D Status and Technology Source, Raw Materials Sources Analysis; Chapter 4, Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment); Chapter 5 and 6, Regional Market Analysis that includes United States, China, Europe, Japan, Korea & Taiwan, Biopsy Devices Segment Market Analysis (by Type); Chapter 7 and 8, The Biopsy Devices Segment Market Analysis (by Application) Major Manufacturers Analysis of Biopsy Devices; Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type Natural preservative, Chemical preservative, Market Trend by Application; Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis; Chapter 11, The Consumers Analysis of Global Biopsy Devices; Chapter 12, Biopsy Devices Research Findings and Conclusion, Appendix, methodology and data source; Chapter 13, 14 and 15, Biopsy Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source. Else Place An Inquire Before Purchase “Global Biopsy Devices Market Size, Status and Forecast 2026: https://www.coherentmarketinsights.com/insight/talk-to-analyst/220 Key questions answered in Biopsy Devices Market report: • What will the Market size be in 2026 and what will the growth rate be? • What are the key Market trends? • What is driving this Market? • What are the challenges to Market growth? • Who are the key vendors in this Market space? • What are the Market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? About Coherent Market Insights: Coherent Market Insights is a prominent Market research and consulting firm offering action-ready syndicated research reports, custom Market analysis, consulting services, and competitive analysis through various recommendations related to emerging Market trends, technologies, and potential absolute dollar opportunity. Post Views: 4

Intact Medical Frequently Asked Questions (FAQ)

  • When was Intact Medical founded?

    Intact Medical was founded in 1998.

  • Where is Intact Medical's headquarters?

    Intact Medical's headquarters is located at 550 Cochituate Road, Framingham.

  • What is Intact Medical's latest funding round?

    Intact Medical's latest funding round is Acquired.

  • How much did Intact Medical raise?

    Intact Medical raised a total of $53.18M.

  • Who are the investors of Intact Medical?

    Investors of Intact Medical include Medtronic, MedVenture Associates, Morgenthaler Ventures, ABS Ventures, Sapient Capital and 5 more.

  • Who are Intact Medical's competitors?

    Competitors of Intact Medical include Itamar Medical, Veran Medical Technologies, IlluminOss Medical, FloShield, Cabochon Aesthetics and 13 more.

Compare Intact Medical to Competitors

V
Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

Endologix Logo
Endologix

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA. Endologix is currently marketing its Powerlink Delivery System a, one-piece endoluminal stent graft (ELG) used in treating AAA that has significant advantages when compared with marketed stent alternatives. Powerlink has been commercially available in Europe since 1999. FDA approval for the Powerlink AAA stent graft was received on October 29, 2004. The Powerlink superior design is covered by 17 U.S. patents with 361 allowed claims; the technology is designed to overcome shortcomings of first-generation ELGs. The device is for sale in the United States and selected international markets. Endologix is a publicly-held company trading on NASDAQ: ELGX. The company's corporate office is located in Irvine, California.

B
Biopsys Medical

News of a breast biopsy raises many emotions and concerns. The company understand. But it's important to remember that 80% of breast biopsies do not turn out to be breast cancer. It's also important to know that users have options when selecting a biopsy procedure. This site is dedicated to evaluating their choices to help users talk with their doctor about the breast biopsy procedure that is right for users. One of those choices is a minimally invasive breast biopsy for breast cancer diagnosis using the Mammotome Breast Biopsy System. Mammotome is made available by Ethicon Endo-Surgery, Inc.

P
PreMD

PreMD Inc. is dedicated to saving and improving people's lives with simple, painless and patient-friendly tests that can detect life-threatening illnesses at a. The company's tests do not require any patient preparation or dietary restrictions and can be performed at the point of care, in a laboratory setting and, in some cases, even at home. The company's cardiovascular risk assessment technology, PREVU* Skin Sterol Test, assesses a patient's risk of heart disease by non-invasively measuring the amount of cholesterol in the skin tissues. PreMD's non- or minimally-invasive tests for early-stage colorectal, lung and breast cancers detect a cancer-associated sugar in a sample of rectal mucus, sputum and breast nipple aspirate fluid, respectively. The company's cancer tests are in development.

R
RadioTherapeutics

RadioTherapeutics Corporation is developing tools for minimally invasive treatment of solid tumors. The RF 2000B is used by surgeons, interventional radiologists, and gastroenterologists to predictably, precisely and homogeneously ablate diseased or unwanted volumes of soft tissues.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.